SMN1 and proximal spinal muscular atrophy: In other motor neuron diseases, such as spinal muscular atrophy (SMA), a significant reduction of plasma pNfH was found after treatment initiation with nusinersen, an ASO targeting SMN1 splicing, in children with SMA [115].